Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines

Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells

(2013) Nadine Rathmanner et al.   FEBS LETTERS

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy

(2011) Dana Faratian et al.   PLoS One

Pathological roles of MAPK signaling pathways in human diseases

(2010) Eun Kyung Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities

(2010) Christoph-Erik Mayer et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C

(2010) Simge Akbulut et al.   MOLECULAR BIOLOGY OF THE CELL

Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPAR  in Non-Small Cell Lung Cancer

(2010) M. A. Tennis et al.   MOLECULAR CANCER RESEARCH

Diverse somatic mutation patterns and pathway alterations in human cancers

(2010) Zhengyan Kan et al.   NATURE

Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas

(2010) C Holgren et al.   ONCOGENE

SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity

(2010) A Barbáchano et al.   ONCOGENE

Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease

(2009) F. Edwin et al.   MOLECULAR PHARMACOLOGY

Modulation of Endocrine Pancreas Development but not  -Cell Carcinogenesis by Sprouty4

(2008) F. Jaggi et al.   MOLECULAR CANCER RESEARCH